C

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Director, Program Management

Program ManagementConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • A bachelor’s degree in science or a related field is required.
  • At least 10 years of relevant experience in the biotech or pharmaceutical industry, with increasing responsibility in drug development.
  • Proficiency with Microsoft Office programs, including PowerPoint, Word, Excel, SharePoint, and Teams, as well as Smartsheet and other communication and program management tools.
  • Understanding of current and evolving artificial intelligence tool capabilities and limitations.
  • Strong analytical, strategic-thinking, and problem-solving skills.
  • Ability to communicate clearly, openly, and consistently in a timely manner.
  • Experience building and maintaining program-level budgets and long-range plans.
  • Ability to influence across all organizational levels without direct authority.
  • Ability to thrive in a fast-paced, ambiguous environment while managing competing priorities.
  • Ability to prioritize multiple team deliverables and workstreams with a sense of urgency.
  • Demonstrated experience working with highly effective teams.
  • Ability to guide teams and organizations in productive discussions and complex, data-driven decision-making.
  • Proven ability to establish and maintain trust-based relationships with team members and stakeholders.
  • Ability to maintain individual responsibility and accountability while working toward collective achievement.
  • Commitment to fostering a diverse and inclusive workplace.

Responsibilities

  • Lead the operations of one or more cross-functional Program Teams, focusing on priorities, goal achievement, resources, and maintaining a challenging, collaborative, and sustainable team environment.
  • Partner with the Program Team Leader to identify near-, mid-, and long-term team priorities and propose paths forward, including facilitating strategic decision-making.
  • Communicate program status, priorities, risks and mitigations, and needs clearly and openly to the Program Team, senior leadership, and other stakeholders.
  • Drive execution of the established program vision and strategy, emphasizing quality, speed, and cost.
  • Facilitate the creation and maintenance of core program strategy documents, including the Target Product Profile, Clinical Development Plan, and Regulatory Strategy, in collaboration with cross-functional representatives and in alignment with the overall program strategy.
  • Support functional strategic and annual planning with current, fit-for-purpose materials for functional leaders and team representatives.
  • Create and maintain detailed cross-functional plans, integrated program plans, and visualizations.
  • Maintain current knowledge of the evolving PD(L)-1/VEGF bispecific and antibody-drug conjugate competitive landscape.
  • Drive development and maintenance of the program-level budget and long-range plan in close collaboration with Finance and the cross-functional team.
  • Provide alliance management support for the program, if applicable.

Desired Qualifications

  • An advanced degree in a scientific discipline or an MBA is preferred.

About the Company

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Crescent Biopharma develops oncology therapies for solid tumors, led by CR-001, a tetravalent bispecific antibody that blocks PD-1 and VEGF to boost anti-tumor immunity while inhibiting tumor blood vessel growth. CR-001 sits in a global Phase 1/2 ASCEND trial, and the pipeline also includes CR-002, an anti-PD-L1 antibody-drug conjugate, and CR-003, an ITGB6-targeted ADC. The company differentiates itself by combining immune checkpoint blockade with VEGF inhibition and other targeted modalities to build an immuno-oncology backbone for solid tumors, supported by strategic partnerships and substantial private placements. Crescent’s goal is to advance multi-agent regimens toward regulatory approval and commercial development for patients with solid tumors.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2003

Recently Posted Jobs

Explore more opportunities at Crescent Biopharma

See more jobs